Gfp - that's a very true point: we know that Ampakines work in two indications - ADHD and RD. That's a lot more than many other small cash strapped bios can say.
Sooner or later I believe that fact will translate to an extremely nice appreciation in COR shares.
The million dollar questions are how long until that happens, and what pps level will it happen from?
If there's one thing we all should have learned by now, it's that EVERYTHING with Cortex (and most bios) takes longer than expected.
Thus I still have a big concern that the RD deal time frame is still a ways out - for a variety of reasons I'm sure are probably all legitimate - but with the end result being the same: Cortex having to raise some cash prior to the RD deal.
I am glad to see Neuro's expectation of a January deal... and I'll hold out hope that Jerry's December prediction still comes true.
News 
Market Data 
Discover 
AI
